Jeffrey Aronin, Founder of Emalex Biosciences

Jeffrey Aronin is the founder of Emalex Biosciences. Emalex Biosciences has raised $285M in total funding. Latest round: Series D.

About Jeffrey Aronin

Jeffrey Aronin is the founder and CEO of Emalex Biosciences, a biopharmaceutical company focused on developing therapies for Tourette syndrome. He previously founded and served as CEO of Paragon Biosciences, which played a key role in Emalex's funding.

Jeffrey Aronin at a glance

More founders in Northbrook, United States (44)

Browse related founder lists (6)

Full founder directory · Investor directory · Company funding database · Fundraising library